Position in SUPN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,188,870
+$45,770 QoQ
Shares Held
23,000
0.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $36,352,371 across 10 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
332,900 | $10,026,948 | |
| 2 | PRGO |
PERRIGO Co plc
|
893,359 | $9,594,675 | |
| 3 | ZTS |
Zoetis Inc.
|
60,450 | $7,145,794 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
134,250 | $3,212,602 | |
| 5 | VTRS |
Viatris Inc
|
213,200 | $2,880,332 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
24,000 | $1,820,400 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
23,000 | $1,188,870 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
56,000 | $302,400 |
All Filings in SUPN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,188,870 | 23,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,143,100 | 23,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $840,626 | 17,590 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $554,436 | 17,590 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||